PT - JOURNAL ARTICLE AU - Zanettini, Claudio AU - Omar, Mohamed AU - Dinalankara, Wikum AU - Imada, Eddie Luidy AU - Colantuoni, Elizabeth AU - Parmigiani, Giovanni AU - Marchionni, Luigi TI - Influenza Vaccination and COVID19 Mortality in the USA AID - 10.1101/2020.06.24.20129817 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.24.20129817 4099 - http://medrxiv.org/content/early/2020/06/26/2020.06.24.20129817.short 4100 - http://medrxiv.org/content/early/2020/06/26/2020.06.24.20129817.full AB - COVID-19 mortality rate is higher in the elderly and in those with preexisting chronic medical conditions. The elderly also suffer from increased morbidity and mortality from seasonal influenza infection, and thus annual influenza vaccination is recommended for them.In this study, we explore a possible area-level association between influenza vaccination coverage in people aged 65 years and older and the number of deaths from COVID-19. To this end, we used COVID-19 data until June 10, 2020 together with population health data for the United States at the county level. We fit quasi-Poisson regression models using influenza vaccination coverage in the elderly population as the independent variable and the number of deaths from COVID-19 as the outcome variable. We adjusted for a wide array of potential confounding variables using both county-level generalized propensity scores for influenza vaccination rates, as well as direct adjustment.Our results suggest that influenza vaccination coverage in the elderly population is negatively associated with mortality from COVID-19. This finding is robust to using different analysis periods, different thresholds for inclusion of counties, and a variety of methodologies for confounding adjustment.In conclusion, our results suggest a potential protective effect of the influenza vaccine on COVID-19 mortality in the elderly population. The significant public health implications of this possibility point to an urgent need for studying the relationship between influenza vaccination and COVID-19 mortality at the individual level, to investigate both the epidemiology and any underlying biological mechanism.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis publication was made possible through support from the NIH-NCI grants P30CA006973 (L.M.)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study, along with detailed information about the data sources, are available in the form of the R package covid19census, freely distributed from GitHub. All scripts and codes used to pre-process and analyze data are also available On GitHub using the links below. https://github.com/c1au6i0/covid19census https://github.com/c1au6i0/covid19_influenza